Case-mix adjusted percentage of cancers diagnosed at stages 1 and 2 by sub-ICB in England, 2021

Comments on this briefing are welcomed. In particular, comments on the following items are sought: 

• additional case-mix variables to consider in future publications: the current variables are age at diagnosis, gender, cancer site/group and deprivation. 
• use of site/group-specific definitions to indicate earlier stage at diagnosis: for example, should ‘early stage’ be considered stages 1, 2 and 3 for breast cancer? This is discussed in further detail in the Technical Documentation for this indicator, however additional views are sought. 

Feedback can be sent to: [email protected]. This email address can be used for general enquiries to NDRS. Please do not include sensitive or patient identifiable information.